EQUIFAX INC false 0000033185 0000033185 2021-05-06 2021-05-06

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): May 6, 2021

 

 

EQUIFAX INC.

(Exact name of registrant as specified in Charter)

 

 

 

GA   001-06605   58-0401110
(State or other jurisdiction
of incorporation)
 

(Commission

File Number)

  (IRS Employer
Identification No.)

 

1550 Peachtree Street N.W.

Atlanta, GA

  30309
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code:(404) 885-8000

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol

 

Name of each exchange

on which registered

Common stock, $1.25 par value per share   EFX   New York Stock Exchange

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

 

 

Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 


Item 5.07

Submission of Matters to a Vote of Security Holders.

On May 6, 2021, Equifax Inc., a Georgia corporation (the “Company”), held its 2021 Annual Meeting of Shareholders (the “Annual Meeting”). A total of 111,558,923 shares were represented in person or by valid proxy at the Annual Meeting and the Company’s shareholders took the following actions:

1. Election of Directors. Shareholders elected ten directors to serve until the next annual meeting of shareholders and until their successors are elected and qualified. The vote totals for each of these individuals is set forth below:

 

Director

  

        Shares For        

  

        Shares Against        

  

        Shares Abstained        

Mark W. Begor

  

106,078,072

  

145,746

  

183,967

Mark L. Feidler

  

91,642,943

  

9,612,582

  

5,152,260

G. Thomas Hough

  

105,823,828

  

390,807

  

193,150

Robert D. Marcus

  

103,965,357

  

2,250,254

  

192,174

Scott A. McGregor

  

105,918,426

  

296,823

  

192,536

John A. McKinley

  

105,079,816

  

1,135,421

  

192,548

Robert W. Selander

  

104,931,683

  

1,289,979

  

186,123

Melissa D. Smith

  

105,565,573

  

654,792

  

187,420

Audrey Boone Tillman

  

106,073,268

  

155,475

  

179,042

Heather H. Wilson

  

106,077,588

  

149,692

  

180,505

There were 5,154,475 broker non-votes with respect to each director nominee listed above.

2. Advisory Vote to Approve Named Executive Officer Compensation. Shareholders approved, on a non-binding, advisory basis, the compensation paid to the Company’s named executive officers. The vote totals were 95,271,407 shares for, 10,709,271 shares against, 427,107 share abstentions and 5,154,475 broker non-votes.

3. Ratification of Appointment of Independent Registered Public Accounting Firm. Shareholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for fiscal year 2021. The vote totals were 110,531,000 shares for, 847,129 shares against and 184,131 share abstentions.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: May 11, 2021   

EQUIFAX INC.

    By:  

/s/ John J. Kelley III

    Name:   John J. Kelley III
    Title:   Corporate Vice President, Chief Legal Officer and Corporate Secretary